Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Return on Capital Employed (2017 - 2021)

Historic Return on Capital Employed for ENDRA Life Sciences (NDRA) over the last 5 years, with Q3 2021 value amounting to 0.73%.

  • ENDRA Life Sciences' Return on Capital Employed rose 38400.0% to 0.73% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.73%, marking a year-over-year increase of 38400.0%. This contributed to the annual value of 1.65% for FY2020, which is 4700.0% up from last year.
  • As of Q3 2021, ENDRA Life Sciences' Return on Capital Employed stood at 0.73%, which was up 38400.0% from 0.69% recorded in Q2 2021.
  • ENDRA Life Sciences' 5-year Return on Capital Employed high stood at 1.26% for Q1 2017, and its period low was 6.27% during Q3 2019.
  • For the 5-year period, ENDRA Life Sciences' Return on Capital Employed averaged around 2.07%, with its median value being 1.37% (2021).
  • As far as peak fluctuations go, ENDRA Life Sciences' Return on Capital Employed tumbled by -19700bps in 2018, and later soared by 42300bps in 2021.
  • Over the past 5 years, ENDRA Life Sciences' Return on Capital Employed (Quarter) stood at 0.78% in 2017, then tumbled by -254bps to 2.75% in 2018, then decreased by -19bps to 3.26% in 2019, then soared by 42bps to 1.89% in 2020, then soared by 62bps to 0.73% in 2021.
  • Its Return on Capital Employed stands at 0.73% for Q3 2021, versus 0.69% for Q2 2021 and 0.84% for Q1 2021.